Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

amgen_hq

Positive Phase III results for Amgen’s Repatha for coronary artery disease

September 21, 2016 Research and Development Amgen, Phase III trial, Repatha

Amgen has announced that its monoclonal antibody Repatha (evolocumab) achieved positive Phase III results for the treatment of coronary artery …
News
shutterstock_273326141

Teva and Regeneron team up for $2.6 billion pain treatment development

September 21, 2016 Research and Development, Sales and Marketing Regeneron, Teva, fasinumab, osteoarthritis

Teva and Regeneron have entered an agreement worth up to $2.6 billion to develop and market the latter’s experimental nerve …
News
microsoft-80658_1280

AstraZeneca and Microsoft to develop ‘drag and drop’ cancer simulation

September 21, 2016 Medical Communications, Research and Development AstraZeneca, Digital Pharma Guide, Microsoft

AstraZeneca has entered into a partnership with tech giant Microsoft to develop a new computerised modelling system which promises to …
News
allergan

Allergan expands NASH portfolio with $1.7 billion in acquisitions

September 21, 2016 Research and Development, Sales and Marketing Akarna Therapeutics, Allergan, Tobira Therapeutics, acqusition, nash

Allergan has gone on a spending spree this week, snapping up clinical-stage biotech Tobira Therapeutics and privately-held Akarna Therapeutics for …
News
a_scientist_at_work_at_sanofis_immunology_laboratory_in_thailand

Sanofi reveals promising data for relapsing remitting MS treatment

September 20, 2016 Manufacturing and Production, Research and Development RRMS, Sanofi, relapsing remitting multiple sclerosis, relapsing-remitting multiple sclerosis

Sanofi Genzyme, the speciality care global business unit of the French pharma firm announced six-year investigational data on Lemtrada (alemtuzumab) …
News
takeda_world

Takeda partners with Zydus to develop chikungunya vaccine

September 20, 2016 Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya

Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …
News
2363

GSK appoints Emma Walmsley as CEO

September 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …
News
Ian Parsons

PCI Pharma Services to Share Expertise at Free Serialization Forum

September 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI Pharma Services

Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …
News
Press release

Ashfield and Patient Connect Form Alliance to Provide Holistic Patient Services

September 19, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

Ashfield Commercial and Medical Services, part of UDG Healthcare plc, a global leader in providing outsourced healthcare services to pharmaceutical, …
News
Press release
Cirrus

Cirrus – a new name for specialist artwork services

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”), a global leader in value-added print and packaging solutions for the pharmaceutical, healthcare and FMCG sectors, …
News
Press release
sanofi-dr-frank-nestle-250

New immunology and inflammation research global head and North American CSO for Sanofi

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, appointment

Sanofi has announced the appointment of Dr Frank Nestle as both the global head of immunology and inflammation research therapeutic …
Appointment
eli_lilly_logo

Levi Garraway to succeed Richard Gaynor as senior VP of Global Oncology at Lilly

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, appointment

Eli Lilly has announced that Dr Levi Garraway will join the company as its senior vice president, Global Development & …
Appointment
allergan

Allergan snaps up Vitae Pharma for $639 million

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Vitae, acquisition

Allergan has agreed to buy clinical-stage biotech Vitae Pharmaceuticals for $639 million, or $21 a share – more than double …
News
c_nito_-_fotolia

UK Biopharma and life after Brexit

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit

Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …
Feature
hero-plus

Mylan CEO to appear before US congress over EpiPen scandal

September 15, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Hilary Clinton, Mylan, epipen

Following the controversy of Mylan’s price increases to its EpiPen (epinephrine) auto-injector, the company’s CEO Heather Bresch is due to …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026